Crewe Advisors’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $829K | Buy |
3,263
+404
| +14% | +$94.2K | 0.06% | 102 |
|
|
2026
Q1 | $699K | Buy |
2,859
+37
| +1% | +$8.62K | 0.06% | 103 |
|
|
2025
Q4 | $584K | Sell |
2,822
-272
| -9% | -$53.8K | 0.05% | 113 |
|
|
2025
Q3 | $574K | Buy |
3,094
+20
| +0.7% | +$3.43K | 0.05% | 113 |
|
|
2025
Q2 | $470K | Buy |
3,074
+38
| +1% | +$5.84K | 0.07% | 95 |
|
|
2025
Q1 | $503K | Sell |
3,036
-50
| -2% | -$7.82K | 0.07% | 78 |
|
|
2024
Q4 | $446K | Sell |
3,086
-841
| -21% | -$130K | 0.06% | 86 |
|
|
2024
Q3 | $636K | Sell |
3,927
-142
| -3% | -$22.6K | 0.07% | 72 |
|
|
2024
Q2 | $595K | Buy |
4,069
+163
| +4% | +$24.2K | 0.07% | 92 |
|
|
2024
Q1 | $618K | Buy |
+3,906
| New | +$622K | 0.07% | 83 |
|
|
2023
Q3 | – | Sell |
-2,125
| Closed | -$352K | – | 752 |
|
|
2023
Q2 | $352K | Sell |
2,125
-526
| -20% | -$84.9K | 0.05% | 100 |
|
|
2023
Q1 | $411K | Buy |
2,651
+130
| +5% | +$21K | 0.06% | 98 |
|
|
2022
Q4 | $445K | Sell |
2,521
-250
| -9% | -$43.2K | 0.07% | 86 |
|
|
2022
Q3 | $453K | Buy |
2,771
+191
| +7% | +$32.3K | 0.08% | 80 |
|
|
2022
Q2 | $458K | Buy |
2,580
+1,184
| +85% | +$211K | 0.1% | 64 |
|
|
2022
Q1 | $248K | Buy |
1,396
+630
| +82% | +$107K | 0.05% | 97 |
|
|
2021
Q4 | $131K | Buy |
766
+357
| +87% | +$58.4K | 0.03% | 117 |
|
|
2021
Q3 | $66K | Hold |
409
| – | – | 0.02% | 136 |
|
|
2021
Q2 | $67K | Hold |
409
| – | – | 0.02% | 138 |
|
|
2021
Q1 | $67K | Buy |
409
+195
| +91% | +$31.6K | 0.02% | 131 |
|
|
2020
Q4 | $34K | Sell |
214
-119
| -36% | -$17.6K | 0.01% | 164 |
|
|
2020
Q3 | $50K | Buy |
333
+300
| +909% | +$44.4K | 0.02% | 128 |
|
|
2020
Q2 | $5K | Hold |
33
| – | – | ﹤0.01% | 181 |
|
|
2020
Q1 | $4K | Sell |
33
-35
| -51% | -$4.97K | ﹤0.01% | 160 |
|
|
2019
Q4 | $10K | Buy |
68
+35
| +106% | +$4.75K | ﹤0.01% | 182 |
|
|
2019
Q3 | $4K | Sell |
33
-190
| -85% | -$25K | ﹤0.01% | 196 |
|
|
2019
Q2 | $31K | Buy |
223
+196
| +726% | +$27.1K | 0.01% | 164 |
|
|
2019
Q1 | $4K | Sell |
27
-323
| -92% | -$43.3K | ﹤0.01% | 201 |
|
|
2018
Q4 | $45K | Buy |
350
+150
| +75% | +$20.9K | 0.01% | 117 |
|
|
2018
Q3 | $28K | Sell |
200
-294
| -60% | -$39.1K | 0.02% | 156 |
|
|
2018
Q2 | $60K | Sell |
494
-80
| -14% | -$9.98K | 0.06% | 106 |
|
|
2018
Q1 | $74K | Buy |
574
+74
| +15% | +$10K | 0.07% | 90 |
|
|
2017
Q4 | $70K | Buy |
+500
| New | +$69.6K | 0.07% | 100 |
|
Other funds holding JNJ
Crewe Advisors's JNJ Position: Q2 2026 in Review
Crewe Advisors increased its Johnson & Johnson (JNJ) stake by 14% in Q2 2026, buying an estimated $94.2K and bringing the position to 3,263 shares worth $829K. The position accounts for 0.06% of the portfolio, ranked #102.
Crewe Advisors first reported a position in JNJ in Q4 2017 and has held it in 33 quarters since. 2,980 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Crewe Advisors held 3,263 shares of Johnson & Johnson worth $829K as of Q2 2026.
- Crewe Advisors bought 404 Johnson & Johnson shares in Q2 2026, an estimated $94.2K.
- Johnson & Johnson made up 0.06% of Crewe Advisors's portfolio in Q2 2026, its #102 holding.
- Crewe Advisors first reported a position in Johnson & Johnson in Q4 2017 and has held it in 33 quarters since.
- 2,980 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Crewe Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.